Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-008884
Filing Date
2025-05-06
Accepted
2025-05-07 09:07:00
Documents
10
Period of Report
2025-05-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 87195
2 GRAPHIC formdef14a_001.jpg GRAPHIC 2738
3 GRAPHIC formdef14a_002.jpg GRAPHIC 3595
4 GRAPHIC formdef14a_003.jpg GRAPHIC 4103
5 GRAPHIC formdef14a_004.jpg GRAPHIC 2926
6 GRAPHIC formdef14a_005.jpg GRAPHIC 938
7 GRAPHIC formdef14a_006.jpg GRAPHIC 921
8 GRAPHIC formdef14a_007.jpg GRAPHIC 921
9 GRAPHIC formdef14a_008.jpg GRAPHIC 1255
10 GRAPHIC formdef14a_009.jpg GRAPHIC 1274
  Complete submission text file 0001641172-25-008884.txt   115358
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41488 | Film No.: 25919527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)